Delaying these rules will not reduce drug prices, but will shield a broken industry that urgently needs market reforms to drive down costs. Big Pharma and  Big Health Insurance should not be allowed to use PBMs to cut back room deals while consumers pay more! https://t.co/szPv7mmPCk